J.P. Morgan 2019: Biopharma Sentiment Soars As Deal And Financing Optimism Abounds

 
• By Mandy Jackson

Biopharma investor sentiment plunged at the end 2018, but soared as the J.P. Morgan Healthcare Conference kicked off with another big company acquisition and as industry participants indicated their optimism about financing and deal-making opportunities in 2019.

San Francisco skyline retro view. America spirit - California theme. USA background. - Image

More from Deals

More from Business